Literature DB >> 31169348

Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses.

Panagiotis I Georgianos1, Pantelis E Zebekakis1, Vassilios Liakopoulos1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31169348      PMCID： PMC8030299          DOI： 10.1111/jch.13580

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  14 in total

Review 1.  Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.

Authors:  Charalambos Vlachopoulos; Konstantinos Aznaouridis; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

Review 2.  Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients.

Authors:  Panagiotis I Georgianos; Pantelis A Sarafidis; Anastasios N Lasaridis
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

3.  Similarities and Differences Between the ACC/AHA and ESH/ESC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Authors:  George Bakris
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

Review 4.  The Management of Hypertension in 2018: What Should the Targets Be?

Authors:  Waleed Ali; George Bakris
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

Review 5.  What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?

Authors:  Gopesh K Modi; Rajiv Agarwal
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.

Authors:  Esa M Davis; Lawrence J Appel; Xuelei Wang; Tom Greene; Brad C Astor; Mahboob Rahman; Robert Toto; Michael S Lipkowitz; Velvie A Pogue; Jackson T Wright
Journal:  Hypertension       Date:  2011-05-09       Impact factor: 10.190

8.  The role of diastolic blood pressure when treating isolated systolic hypertension.

Authors:  G W Somes; M Pahor; R I Shorr; W C Cushman; W B Applegate
Journal:  Arch Intern Med       Date:  1999-09-27

9.  Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.

Authors:  Srinivasan Beddhu; Glenn M Chertow; Alfred K Cheung; William C Cushman; Mahboob Rahman; Tom Greene; Guo Wei; Ruth C Campbell; Margaret Conroy; Barry I Freedman; William Haley; Edward Horwitz; Dalane Kitzman; James Lash; Vasilios Papademetriou; Roberto Pisoni; Erik Riessen; Clive Rosendorff; Suzanne G Watnick; Jeffrey Whittle; Paul K Whelton
Journal:  Circulation       Date:  2017-10-11       Impact factor: 29.690

10.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.